As the pediatric cancer charity celebrates its 20th anniversary, Cornerstone is highlighting the groundbreaking research at CHOP fueled by two decades of collaboration.
Dr. Wang directs the Cell Based Therapy Lab (CBTL) at CHOP. The CBTL is a cGMP facility manufacturing cell and gene therapy products for use in bone marrow transplant, adoptive immune therapy, and many other cutting edge applications in medicine.
The Li Lab develops cutting-edge computational programs for analyzing large cancer genomics data, with a focus on understanding tumor-immune interactions.
